Methy Meditech Co., Ltd. is a Company Limited, established on 9 Nov 2015 and registered in Chonburi, Thailand. The Company’s principal business is manufacture of other food products, not elsewhere classified. Methy Meditech Co., Ltd. has been operating for 10 years and its current status is Active.
Profile
Company DetailsCompany record
- Legal name
- Methy Meditech Co., Ltd.
- Registration number
- 0105558178859
- Entity type
- Company Limited
- Status
- Active
- Registered date
- 9 Nov 2015
- Registered capital (THB)
- THB 1,000,000
- Industry group
- Manufacturing
- TSIC activity
- Manufacture of other food products, not elsewhere classified
Contact DetailsRegistered contact information
- Registered address
- 168/43, Moo 3, Nong Pla Lai, Bang Lamung, Chon Buri 20150
- Operational address
- Locked🔒
- Website
- Locked🔒
- Telephone
- Locked🔒
People
ManagementRecorded directors and signatory
- Methikha SopakulvijitraDirector
ShareholderShareholding of Methy Meditech Co., Ltd.
Ownership records and shareholder relationships require premium access.
- ✓Shareholder names and holdings
- ✓Ownership percentages and changes
Financial
Credit RatingCredit rating for Methy Meditech Co., Ltd.
Credit assessment and supporting financial indicators require premium access.
- ✓Credit rating and payment profile
- ✓Financial strength and risk indicators
Risk
Government ConnectionGovernment connection checks for Methy Meditech Co., Ltd.
Government ownership, control, and politically exposed person links require premium access.
- ✓Government ownership and control checks
- ✓Politically exposed person links
Litigation checks for Methy Meditech Co., Ltd.
Court records and material dispute intelligence require premium access.
- ✓Civil and commercial court records
- ✓Case status and material outcomes
Regulatory checks for Methy Meditech Co., Ltd.
Regulatory actions, sanctions, and compliance findings require premium access.
- ✓Regulatory actions and sanctions
- ✓Licence and compliance findings
Adverse media checks for Methy Meditech Co., Ltd.
Source-screened media coverage and reputational risk signals require premium access.
- ✓Source-screened media coverage
- ✓Material allegations and reputational signals
